These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15641988

  • 1. Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy.
    Takemura K, Noguchi M, Ogi K, Tokino T, Kubota H, Miyazaki A, Kohama G, Hiratsuka H.
    J Oral Pathol Med; 2005 Feb; 34(2):93-9. PubMed ID: 15641988
    [Abstract] [Full Text] [Related]

  • 2. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
    Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M.
    Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
    [Abstract] [Full Text] [Related]

  • 3. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
    Kawakami K, Tsukuda M, Mizuno H, Nishimura G, Ishii A, Hamajima K.
    Anticancer Res; 1999 Apr; 19(5B):3927-32. PubMed ID: 10628333
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
    Ikeguchi M, Nakamura S, Kaibara N.
    Oncol Rep; 2002 Apr; 9(5):1121-6. PubMed ID: 12168083
    [Abstract] [Full Text] [Related]

  • 5. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D.
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [Abstract] [Full Text] [Related]

  • 6. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, Kannan S, Pathak KA, Choudhary M, Teni TR.
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [Abstract] [Full Text] [Related]

  • 7. Induction of apoptosis by paclitaxel in human oral carcinoma cells.
    Nonaka M, Ikeda H, Fujisawa A, Uehara M, Inokuchi T.
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):649-52. PubMed ID: 16513327
    [Abstract] [Full Text] [Related]

  • 8. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
    Olejniczak SH, Hernandez-Ilizaliturri FJ, Clements JL, Czuczman MS.
    Clin Cancer Res; 2008 Mar 01; 14(5):1550-60. PubMed ID: 18316580
    [Abstract] [Full Text] [Related]

  • 9. [Bax protein expression in the carcinogenesis of human oral mucosa].
    Zeng X, Chen Q, Li B, Tan N.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr 01; 18(2):88-90. PubMed ID: 12539337
    [Abstract] [Full Text] [Related]

  • 10. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T, Kato Y, Baba Y, Nishimura G, Tanigaki Y, Horiuchi C, Mochimatsu I, Tsukuda M.
    Oncol Rep; 2004 Feb 01; 11(2):421-6. PubMed ID: 14719078
    [Abstract] [Full Text] [Related]

  • 11. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma].
    Guan W, Yu S, Gao Y.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan 01; 37(1):65-8. PubMed ID: 11955367
    [Abstract] [Full Text] [Related]

  • 12. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Toyota H, Kondo S, Kyo S, Mizuguchi J.
    Anticancer Res; 2006 Jan 01; 26(1A):99-105. PubMed ID: 16475685
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Yamamoto E.
    J Oral Pathol Med; 2008 Jul 01; 37(6):364-71. PubMed ID: 18410312
    [Abstract] [Full Text] [Related]

  • 14. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2005 Jul 01; 25(4):2749-55. PubMed ID: 16080521
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, Tian Z, Chen W.
    J Oral Pathol Med; 2009 Mar 01; 38(3):307-13. PubMed ID: 18710422
    [Abstract] [Full Text] [Related]

  • 16. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 01; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I, Jiang H, Thode B, Doehn C, Krüger S, Jocham D.
    Eur Urol; 2005 May 01; 47(5):703-9. PubMed ID: 15826766
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
    Tirado OM, Mateo-Lozano S, Notario V.
    Oncogene; 2005 May 05; 24(20):3348-57. PubMed ID: 15782132
    [Abstract] [Full Text] [Related]

  • 19. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 05; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 20. Expression of apoptosis-related proteins in advanced uterine cervical cancer after balloon-occluded arterial infusion chemotherapy as an indicator of the efficiency of this therapy.
    Okamoto E, Sumi T, Misugi F, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.
    Int J Mol Med; 2005 Jan 05; 15(1):41-7. PubMed ID: 15583826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.